Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Cash Flow Reinvestment Rate
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥54.40 Million (capex CN¥54.40 Million ) from operating cash flow of CN¥281.88 Million. See free cash flow generation of Shaanxi Meibang Pharmaceutical Group Co to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Shaanxi Meibang Pharmaceutical Group Co Ltd across 7 annual periods. For the full cash flow conversion analysis, see Shaanxi Meibang Pharmaceutical Group Co (605033) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year capital reinvestment analysis for Shaanxi Meibang Pharmaceutical Group Co Ltd. See Shaanxi Meibang Pharmaceutical Group Co (605033) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.92x | CN¥539.05 Million | CN¥280.40 Million | CN¥158.81 Million | ▲ +123.3% |
| 2023 | 0.86x | CN¥288.20 Million | CN¥334.79 Million | CN¥203.69 Million | ▼ -24.3% |
| 2022 | 1.14x | CN¥143.69 Million | CN¥126.41 Million | CN¥109.29 Million | ▼ -19.1% |
| 2020 | 1.40x | CN¥105.20 Million | CN¥74.88 Million | CN¥61.71 Million | ▲ +218.4% |
| 2019 | 0.44x | CN¥56.69 Million | CN¥128.45 Million | CN¥33.78 Million | ▼ -78.5% |
| 2018 | 2.06x | CN¥34.86 Million | CN¥16.96 Million | CN¥34.86 Million | ▲ +244.2% |
| 2017 | 0.60x | CN¥17.56 Million | CN¥29.41 Million | CN¥17.56 Million | — |